Siemens Healthineers AG (ETR:SHL)
Germany
· Delayed Price · Currency is EUR 46.58
-0.49 (-1.04%)
May 30, 2025, 5:35 PM CET
Revenue by Product
Fiscal year is October - September.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2015 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | 2015 - 2020 |
| Imaging | 12.81B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Imaging Growth | 7.36% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Diagnostics | 4.44B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Diagnostics Growth | -0.40% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Advanced Therapies | 2.13B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Advanced Therapies Growth | 3.81% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Eliminations from | -303.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Eliminations from Growth | 18.82% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Varian | 4.06B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Varian Growth | 10.39% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is October - September.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2015 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | 2015 - 2020 |
| EMEA | 7.46B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| EMEA Growth | 2.47% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Americas | 10.10B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Americas Growth | 12.30% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia and Australia Revenue (Pre-FY2023 Reporting) | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia and Australia Revenue (Pre-FY2023 Reporting) Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia Pacific Japan Revenue (Post-FY2022 Reporting) | 3.06B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia Pacific Japan Revenue (Post-FY2022 Reporting) Growth | 4.72% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China | 2.53B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China Growth | -5.56% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other
Fiscal year is October - September.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2015 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | 2015 - 2020 |
| Imaging Income Before Taxes | 2.75B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Imaging Income Before Taxes Growth | 23.08% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Diagnostics Income Before Taxes | 290.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Diagnostics Income Before Taxes Growth | 57.78% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Advanced Therapies Income Before Taxes | 357.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Advanced Therapies Income Before Taxes Growth | 20.00% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Eliminations from Income Before Taxes | -1.27B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Eliminations from Income Before Taxes Growth | -5.93% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Varian Income Before Taxes | 649.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Varian Income Before Taxes Growth | -7.38% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Equipment Book-to-Bill Ratio | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|